Somai Pharmaceuticals Partners with Airo Brands for Global Expansion

Business by 2FIRSTS.ai
Feb.07.2024
Somai Pharmaceuticals Partners with Airo Brands for Global Expansion
Portuguese pharmaceutical company Somai Pharmaceuticals announced its entry into the Australian market in collaboration with Airo Brands.

Portuguese-based pharmaceutical company Somai Pharmaceuticals recently announced its entry into the Australian market. The company plans to collaborate with American e-cigarette company Airo Brands to manufacture and distribute a range of e-cigarette and e-liquid products.

 

Pharmaceutical company Somei operates a 3800-square-meter factory near Lisbon, where it exclusively produces the Airo e-cigarette battery technology and its AiroPod e-liquid formula. The first batch of products is expected to be launched in the second quarter of this year under the Special Access Scheme, and sales are also anticipated in Germany, Poland, and Switzerland.

 

Airo Company was established in 2017 and its innovative tobacco products have been licensed for sale in more than 1700 medical and adult-use marijuana dispensaries across 23 states in the United States and Puerto Rico.

 

For Solmax, a company engaged in the extraction, research, development, formulation, and distribution of pharmaceutical cannabis products complying with EU GMP regulations, the Airo product holds the potential to become their first batch of products distributed in Australia.

 

Somai Founder and CEO, Michael Sassano, expressed that this collaboration will position Airo "ahead of other companies in global expansion." He stated, "Our Airo products will meet the European Union GMP quality standards worldwide, and as the global market expands, we will propel the entire Airo product range into an even brighter future." Both Europe and other continents are progressing, and we are honored to bring the finest vaporizers to the global market.

 

Richard Yost, CEO of Airo, has referred to this collaboration as a "milestone" and emphasized the significance of finding a partner that shares their commitment to quality and consumer focus. According to Yost, they have identified these qualities in Soma.

 

We were not only impressed by their advanced factory in Portugal, but also by the quality of their team.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Lawmakers Clash as Mexico Moves to Criminalize Sale and Promotion of Vapes
Lawmakers Clash as Mexico Moves to Criminalize Sale and Promotion of Vapes
Mexico’s Chamber of Deputies Health Commission has approved a bill establishing a total ban on vapes and e-cigarettes, with penalties ranging from one to eight years in prison and fines between Mex$11,000 and Mex$226,000 (USD ≈$600–$12,300). The proposal sparked controversy among opposition lawmakers, who argued that the legislation criminalizes users rather than focusing on regulation and prevention.
Nov.26 by 2FIRSTS.ai
$200 Million Investment to Advance Smokeless Product Manufacturing at Reynolds
$200 Million Investment to Advance Smokeless Product Manufacturing at Reynolds
Reynolds American Inc. announced it will create 200 new manufacturing positions in 2026 at its Tobaccoville, North Carolina, Operations Center, bringing total new roles added over the past two years to more than 1,000. The company added 800 jobs between 2024 and 2025. These roles will support the continued growth of Velo Plus nicotine pouches and Reynolds’ expanding multi-category portfolio, aligned with its mission to build a smokeless world.
Dec.11 by 2FIRSTS.ai
AG Miyares Argues Vape Ban Consistent with Federal Law, Seeks Dismissal
AG Miyares Argues Vape Ban Consistent with Federal Law, Seeks Dismissal
Virginia Attorney General Jason Miyares and Tax Commissioner James J. Alex have asked a federal court to dismiss a lawsuit challenging the state’s ban on flavored e-cigarettes. They argue plaintiffs lack standing because the products are already illegal under federal law. The state denies claims of federal preemption and asserts sovereign immunity, maintaining that its ban aligns with its authority to protect public health.
Nov.24 by 2FIRSTS.ai
UK’s Nationwide Crackdown Seizes 111,000 Illegal Vapes in “Machinize 2” Operation
UK’s Nationwide Crackdown Seizes 111,000 Illegal Vapes in “Machinize 2” Operation
UK police have carried out a nationwide crackdown under Operation Machinize 2, targeting illegal vapes, counterfeit goods, and grey-market businesses. Raids on more than 2,700 premises led to 924 arrests and the seizure of 111,000 illegal vapes, 70kg of cannabis, 4.5m cigarettes, and £10.7m in proceeds.
Nov.11 by 2FIRSTS.ai
Expert Warns in 2Firsts Op-ed: Proposed COP11 Ban on Nicotine Pouches Would Be a Global Public Health Mistake
Expert Warns in 2Firsts Op-ed: Proposed COP11 Ban on Nicotine Pouches Would Be a Global Public Health Mistake
As global delegates prepare for COP11, a leaked EU position paper has sparked fresh debate over the future of nicotine pouch regulation. In an exclusive op-ed submitted to 2Firsts, Dr. Nveed Chaudhary, Chair of GINN’s Scientific Committee, argues that banning nicotine pouches would be a profound public health mistake—one that ignores harm reduction science and risks reversing global progress in smoking cessation.
Nov.03
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.
Nov.26